143 related articles for article (PubMed ID: 9279250)
1. Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis.
Imokawa S; Sato A; Hayakawa H; Kotani M; Urano T; Takada A
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):631-6. PubMed ID: 9279250
[TBL] [Abstract][Full Text] [Related]
2. B7-1, B7-2 and class II MHC molecules in idiopathic pulmonary fibrosis and bronchiolitis obliterans-organizing pneumonia.
Kaneko Y; Kuwano K; Kunitake R; Kawasaki M; Hagimoto N; Hara N
Eur Respir J; 2000 Jan; 15(1):49-55. PubMed ID: 10678620
[TBL] [Abstract][Full Text] [Related]
3. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
Takahashi T; Munakata M; Ohtsuka Y; Nisihara H; Nasuhara Y; Kamachi-Satoh A; Dosaka-Akita H; Homma Y; Kawakami Y
Cancer; 2002 Aug; 95(3):624-33. PubMed ID: 12209756
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease.
Martinez JA; King TE; Brown K; Jennings CA; Borish L; Mortenson RL; Khan TZ; Bost TW; Riches DW
Am J Physiol; 1997 Sep; 273(3 Pt 1):L676-83. PubMed ID: 9316504
[TBL] [Abstract][Full Text] [Related]
5. Proteoglycan deposition in pulmonary fibrosis.
Bensadoun ES; Burke AK; Hogg JC; Roberts CR
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1819-28. PubMed ID: 8970376
[TBL] [Abstract][Full Text] [Related]
6. Involvement of collagen-binding heat shock protein 47 and procollagen type I synthesis in idiopathic pulmonary fibrosis: contribution of type II pneumocytes to fibrosis.
Iwashita T; Kadota J; Naito S; Kaida H; Ishimatsu Y; Miyazaki M; Ozono Y; Kohno S
Hum Pathol; 2000 Dec; 31(12):1498-505. PubMed ID: 11150375
[TBL] [Abstract][Full Text] [Related]
7. Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis.
Parra ER; Teodoro WR; de Morais J; Katayama ML; de Souza R; Yoshinari NH; Capelozzi VL
Eur J Clin Invest; 2010 Feb; 40(2):110-20. PubMed ID: 19968698
[TBL] [Abstract][Full Text] [Related]
8. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation.
Mark EJ; Ruangchira-urai R
Ann Diagn Pathol; 2008 Jun; 12(3):171-80. PubMed ID: 18486892
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
10. Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis.
Fujii M; Hayakawa H; Urano T; Sato A; Chida K; Nakamura H; Takada A
Thromb Res; 2000 Jul; 99(2):111-7. PubMed ID: 10946084
[TBL] [Abstract][Full Text] [Related]
11. Proliferative activity in fibrosing lung diseases: a comparative study of Ki-67 immunoreactivity in diffuse alveolar damage, bronchiolitis obliterans-organizing pneumonia, and usual interstitial pneumonia.
El-Zammar O; Rosenbaum P; Katzenstein AL
Hum Pathol; 2009 Aug; 40(8):1182-8. PubMed ID: 19368952
[TBL] [Abstract][Full Text] [Related]
12. Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia.
Kuwano K; Kawasaki M; Maeyama T; Hagimoto N; Nakamura N; Shirakawa K; Hara N
Chest; 2000 Aug; 118(2):451-8. PubMed ID: 10936140
[TBL] [Abstract][Full Text] [Related]
13. [Expression of human leukocyte antigen-DR in idiopathic pulmonary fibrosis].
Ni LF; Na J; Deng R; Wu R; Liu XM
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):622-4. PubMed ID: 18646719
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease.
Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W
Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238
[TBL] [Abstract][Full Text] [Related]
15. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
16. The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis.
Cao B; Guo Z; Zhu Y; Xu W
Chin Med J (Engl); 2000 Sep; 113(9):776-82. PubMed ID: 11776068
[TBL] [Abstract][Full Text] [Related]
17. VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia.
Lappi-Blanco E; Soini Y; Kinnula V; Pääkkö P
J Pathol; 2002 Feb; 196(2):220-7. PubMed ID: 11793374
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis.
Piguet PF; Ribaux C; Karpuz V; Grau GE; Kapanci Y
Am J Pathol; 1993 Sep; 143(3):651-5. PubMed ID: 8362967
[TBL] [Abstract][Full Text] [Related]
19. Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis.
Smith DR; Kunkel SL; Standiford TJ; Rolfe MW; Lynch JP; Arenberg DA; Wilke CA; Burdick MD; Martinez FJ; Hampton JN
Am J Respir Crit Care Med; 1995 Jun; 151(6):1965-73. PubMed ID: 7767546
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations.
Calabrese F; Lunardi F; Giacometti C; Marulli G; Gnoato M; Pontisso P; Saetta M; Valente M; Rea F; Perissinotto E; Agostini C
Thorax; 2008 Sep; 63(9):795-802. PubMed ID: 18344408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
